Cite
The risks of breast and ovarian cancer associated with the Ashkenazi Jewish founder allele BRCA2 6174delT.
MLA
Finch, Amy, et al. “The Risks of Breast and Ovarian Cancer Associated with the Ashkenazi Jewish Founder Allele BRCA2 6174delT.” Clinical Genetics, vol. 101, no. 3, Mar. 2022, pp. 317–23. EBSCOhost, https://doi.org/10.1111/cge.14098.
APA
Finch, A., Metcalfe, K., Akbari, M., Friedman, E., Tung, N., Rosen, B., Eisen, A., Karlan, B., Foulkes, W., Neuhausen, S. L., Senter, L., McKinnon, W., Elser, C., Sun, P., & Narod, S. A. (2022). The risks of breast and ovarian cancer associated with the Ashkenazi Jewish founder allele BRCA2 6174delT. Clinical Genetics, 101(3), 317–323. https://doi.org/10.1111/cge.14098
Chicago
Finch, Amy, Kelly Metcalfe, Mohammad Akbari, Eitan Friedman, Nadine Tung, Barry Rosen, Andrea Eisen, et al. 2022. “The Risks of Breast and Ovarian Cancer Associated with the Ashkenazi Jewish Founder Allele BRCA2 6174delT.” Clinical Genetics 101 (3): 317–23. doi:10.1111/cge.14098.